All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-YC0360 | Anti-DCTN4 (14i130) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 14i130 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0361 | Anti-DCTN4 (14i131) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 14i131 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0362 | Anti-DCTN4 (2244C3a) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 2244C3a | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0363 | Anti-DCTN4 (3G9D7) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 3G9D7 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0364 | Anti-DCTN4 (9j47) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 9j47 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0365 | Anti-DCTN4 (CBYCD-189) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | CBYCD-189 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1260 | Anti-DCTN4 (14i130) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 14i130 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1261 | Anti-DCTN4 (14i131) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 14i131 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1262 | Anti-DCTN4 (2244C3a) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 2244C3a | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1263 | Anti-DCTN4 (3G9D7) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 3G9D7 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1264 | Anti-DCTN4 (9j47) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 9j47 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1265 | Anti-DCTN4 (CBYCD-189) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | CBYCD-189 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION